Table of Contents
ISRN Rheumatology
Volume 2014, Article ID 852954, 7 pages
http://dx.doi.org/10.1155/2014/852954
Review Article

Review of Hyperuricemia as New Marker for Metabolic Syndrome

Department of Medicine, The George Washington University, 2150 Pennsylvania Avenue, NW, Washington, DC 20037, USA

Received 5 August 2013; Accepted 12 December 2013; Published 16 February 2014

Academic Editors: C. V. Albanese, C.-J. Chen, and E. Tchetina

Copyright © 2014 Laura Billiet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Garrod, “Observations on certain pathological conditions of the blood and urine, in gout, rheumatism and Bright’s disease,” Medico-Chirurgical Transactions, vol. 31, pp. 83–97, 1848. View at Google Scholar
  2. J. S. Faires and D. Mccarty Jr., “Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals,” The Lancet, vol. 280, no. 7258, pp. 682–685, 1962. View at Publisher · View at Google Scholar · View at Scopus
  3. H. K. Choi and E. S. Ford, “Prevalence of the metabolic syndrome in individuals with hyperuricemia,” The American Journal of Medicine, vol. 120, no. 5, pp. 442–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. M. Reaven, “Role of insulin resistance in human disease (syndrome X): an expanded definition,” Annual Review of Medicine, vol. 44, pp. 121–131, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-D. Lin, D.-H. Tsai, and S.-R. Hsu, “Association between serum uric acid level and components of the metabolic syndrome,” Journal of the Chinese Medical Association, vol. 69, no. 11, pp. 512–516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. T. W. Yoo, K. C. Sung, H. S. Shin et al., “Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome,” Circulation Journal, vol. 69, no. 8, pp. 928–933, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Onat, H. Uyarel, G. Hergenc et al., “Serum uric acid is a determinant of metabolic syndrome in a population-based study,” American Journal of Hypertension, vol. 19, no. 10, pp. 1055–1062, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kawada, T. Otsuka, M. Katsumata, and H. Suzuki, “Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen,” Journal of the Cardiometabolic Syndrome, vol. 2, no. 3, pp. 158–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Bhole, J. W. Choi, S. W. Kim, M. de Vera, and H. Choi, “Serum uric acid levels and the risk of type 2 diabetes: a prospective study,” The American Journal of Medicine, vol. 123, no. 10, pp. 957–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Ford, C. Li, S. Cook, and H. K. Choi, “Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents,” Circulation, vol. 115, no. 19, pp. 2526–2532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Pacifico, V. Cantisani, C. Anania et al., “Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children,” European Journal of Endocrinology, vol. 160, no. 1, pp. 45–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Rathmann, E. Funkhouser, A. R. Dyer, and J. M. Roseman, “Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults,” Annals of Epidemiology, vol. 8, no. 4, pp. 250–261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Oyama, T. Takahashi, M. Oyamada et al., “Serum uric acid as an obesity-related indicator in early adolescence,” Tohoku Journal of Experimental Medicine, vol. 209, no. 3, pp. 257–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. I. Feig, “Hypertension in adolescents,” Seminars in Nephrology, vol. 25, no. 1, pp. 32–38, 2005. View at Publisher · View at Google Scholar
  15. D. I. Feig, B. Soletsky, and R. J. Johnson, “Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial,” The Journal of the American Medical Association, vol. 300, no. 8, pp. 924–932, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mazzali, J. Hughes, Y.-G. Kim et al., “Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism,” Hypertension, vol. 38, no. 5, pp. 1101–1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Magnus, M. K. Doyle, and S. K. Srivastav, “Serum uric acid and self-reported rheumatoid arthritis in a multiethnic adult female population,” Current Medical Research and Opinion, vol. 26, no. 9, pp. 2157–2163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Daoussis, V. Panoulas, T. Toms et al., “Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis,” Arthritis Research & Therapy, vol. 11, no. 4, article R116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Yang, Y. Liang, W. Xi, Y. Zhu, C. Li, and R. Zhong, “Association of serum uric acid with lupus nephritis in systemic lupus erythematosus,” Rheumatology International, vol. 31, no. 6, pp. 743–748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Sun, H. Brenner, S. Sauerland, K. P. Günther, W. Puhl, and T. Stürmer, “Serum uric acid and patterns of radiographic osteoarthritis—the Ulm Osteoarthritis Study,” Scandinavian Journal of Rheumatology, vol. 29, no. 6, pp. 380–386, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Roddy, W. Zhang, and M. Doherty, “Are joints affected by gout also affected by osteoarthritis?” Annals of the Rheumatic Diseases, vol. 66, no. 10, pp. 1374–1377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. E. Denoble, K. M. Huffman, T. V. Stabler et al., “Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 5, pp. 2088–2093, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Y. Sautin, T. Nakagawa, S. Zharikov, and R. J. Johnson, “Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress,” American Journal of Physiology, vol. 293, no. 2, pp. C584–C596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov, “Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase,” Biochemical Pharmacology, vol. 70, no. 3, pp. 343–354, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Johnson, C. Rivard, T. Nakagawa, Y. Y. Sautin, and L. G. Sanchez-Lozada, “Uric acid: more to learn, more experiments to do,” American Journal of Hypertension, vol. 22, no. 9, pp. 952–953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Schorn, C. Janko, L. Munoz et al., “Sodium and potassium urate crystals differ in their inflammatory potential,” Autoimmunity, vol. 42, no. 4, pp. 314–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Leyva, S. D. Anker, I. F. Godsland et al., “Uric acid in chronic heart failure: a marker of chronic inflammation,” European Heart Journal, vol. 19, no. 12, pp. 1814–1822, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Olexa, M. Olexová, J. Gonsorčík, I. Tkáč, J. Kisel'ová, and M. Olejníková, “Uric acid—a marker for systemic inflammatory response in patients with congestive heart failure?” Wiener Klinische Wochenschrift, vol. 114, no. 5-6, pp. 211–215, 2002. View at Google Scholar · View at Scopus
  29. C. Ruggiero, A. Cherubini, A. Ble et al., “Uric acid and inflammatory markers,” European Heart Journal, vol. 27, no. 10, pp. 1174–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Ruggiero, A. Cherubini, E. Miller III et al., “Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years,” American Journal of Cardiology, vol. 100, no. 1, pp. 115–121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Lyngdoh, P. Marques-Vidal, F. Paccaud et al., “Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based colaus study,” PLoS ONE, vol. 6, no. 5, Article ID e19901, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Zhang, L. Bian, and Y. Choi, “Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men,” Angiology, vol. 63, no. 6, pp. 420–428, 2012. View at Publisher · View at Google Scholar
  33. R. Mutluay, S. M. Deger, E. Bahadir, A. O. Durmaz, R. Çitil, and S. Sindel, “Uric acid is an important predictor for hypertensive early atherosclerosis,” Advances in Therapy, vol. 29, no. 3, pp. 276–286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Fukui, M. Tanaka, E. Shiraishi et al., “Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus,” Metabolism, vol. 57, no. 5, pp. 625–629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Doehner, N. Schoene, M. Rauchhaus et al., “Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies,” Circulation, vol. 105, no. 22, pp. 2619–2624, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Erdogan, H. Gullu, M. Caliskan et al., “Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults,” International Journal of Clinical Practice, vol. 59, no. 11, pp. 1276–1282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Krishnan, B. J. Pandya, L. Chung, and O. Dabbous, “Hyperuricemia and the risk for subclinical coronary atherosclerosis—data from a prospective observational cohort study,” Arthritis Research & Therapy, vol. 13, no. 2, article R66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Ishizaka, Y. Ishizaka, E.-I. Toda, H. Hashimoto, R. Nagai, and M. Yamakado, “Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals,” Atherosclerosis, vol. 192, no. 1, pp. 131–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Takayama, R. Kawamoto, T. Kusunoki, M. Abe, and M. Onji, “Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome,” Cardiovascular Diabetology, vol. 11, article 2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D.-H. Kang, S.-K. Park, I.-K. Lee, and R. J. Johnson, “Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells,” Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 3553–3562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. G. K. Glantzounis, E. C. Tsimoyiannis, A. M. Kappas, and D. A. Galaris, “Uric acid and oxidative stress,” Current Pharmaceutical Design, vol. 11, no. 32, pp. 4145–4151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. So and B. Thorens, “Uric acid transport and disease,” The Journal of Clinical Investigation, vol. 120, no. 6, pp. 1791–1799, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Bagnati, C. Perugini, C. Cau, R. Bordone, E. Albano, and G. Bellomo, “When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid,” Biochemical Journal, vol. 340, no. 1, pp. 143–152, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. U. M. Khosla, S. Zharikov, J. L. Finch et al., “Hyperuricemia induces endothelial dysfunction,” Kidney International, vol. 67, no. 5, pp. 1739–1742, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. C. R. White, T. A. Brock, L. Y. Chang et al., “Superoxide and peroxynitrite in atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 3, pp. 1044–1048, 1994. View at Publisher · View at Google Scholar
  46. F. C. McGillicuddy, M. L. de La Moya, C. C. Hinkle et al., “Inflammation impairs reverse cholesterol transport in vivo,” Circulation, vol. 119, no. 8, pp. 1135–1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Johnson, D.-H. Kang, D. Feig et al., “Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?” Hypertension, vol. 41, no. 6, pp. 1183–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Kanellis, S. Watanabe, J. H. Li et al., “Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2,” Hypertension, vol. 41, no. 6, pp. 1287–1293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. Q. Li, Z. Yang, B. Lu et al., “Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. V. F. Panoulas, H. J. Milionis, K. M. J. Douglas et al., “Association of serum uric acid with cardiovascular disease in rheumatoid arthritis,” Rheumatology, vol. 46, no. 9, pp. 1466–1470, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Sabio, J. A. Vargas-Hitos, J. D. Mediavilla et al., “Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease,” Lupus, vol. 19, no. 5, pp. 591–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, T. R. Vazquez-Rodriguez et al., “Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease,” Seminars in Arthritis and Rheumatism, vol. 39, no. 3, pp. 157–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C. K. Kramer, D. von Mühlen, S. K. Jassal, and E. Barrett-Connor, “Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study,” Diabetes Care, vol. 32, no. 7, pp. 1272–1273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. J. Lee, J. H. Lee, Y. H. Shin, J.-K. Kim, H.-R. Lee, and D.-C. Lee, “Gender difference and determinants of C-reactive protein level in Korean adults,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 7, pp. 863–869, 2009. View at Publisher · View at Google Scholar
  55. E. Bonora, G. Targher, M. B. Zenere et al., “Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study,” International Journal of Obesity and Related Metabolic Disorders, vol. 20, no. 11, pp. 975–980, 1996. View at Google Scholar · View at Scopus
  56. T. Lyngdoh, P. Marques-Vidal, F. Paccaud et al., “Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based colaus study,” PLoS ONE, vol. 6, no. 5, Article ID e19901, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. B. Kirilmaz, F. Asgun, E. Alioglu et al., “High inflammatory activity related to the number of metabolic syndrome components,” The Journal of Clinical Hypertension, vol. 12, no. 2, pp. 136–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. G. Netea, B. J. Kullberg, W. L. Blok, R. T. Netea, and J. W. M. van der Meer, “The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice,” Blood, vol. 89, no. 2, pp. 577–582, 1997. View at Google Scholar · View at Scopus
  59. F. S. di Giovine, S. E. Malawista, E. Thornton, and G. W. Duff, “Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution,” The Journal of Clinical Investigation, vol. 87, no. 4, pp. 1375–1381, 1991. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Bordoni, M. de Cal, M. Rassu et al., “Protective effect of urate oxidase on uric acid induced-monocyte apoptosis,” Current Drug Discovery Technologies, vol. 2, no. 1, pp. 29–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Kono, C.-J. Chen, F. Ontiveros, and K. L. Rock, “Uric acid promotes an acute inflammatory response to sterile cell death in mice,” The Journal of Clinical Investigation, vol. 120, no. 6, pp. 1939–1949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-associated uric acid crystals activate the NALP3 inflammasome,” Nature, vol. 440, no. 7081, pp. 237–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. H. M. Hoffman, P. Scott, J. L. Mueller et al., “Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice,” Arthritis & Rheumatism, vol. 62, no. 7, pp. 2170–2179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. F. Ghaemi-Oskouie and Y. Shi, “The role of uric acid as an endogenous danger signal in immunity and inflammation,” Current Rheumatology Reports, vol. 13, no. 2, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. J. W. Griffith, T. Sun, M. T. McIntosh, and R. Bucala, “Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid,” The Journal of Immunology, vol. 183, no. 8, pp. 5208–5220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Shi, J. E. Evans, and K. L. Rock, “Molecular identification of a danger signal that alerts the immune system to dying cells,” Nature, vol. 425, no. 6957, pp. 516–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Liu-Bryan, P. Scott, A. Sydlaske, D. M. Rose, and R. Terkeltaub, “Innate immunity conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation,” Arthritis & Rheumatism, vol. 52, no. 9, pp. 2936–2946, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Conforti-Andreoni, R. Spreafico, H. L. Qian et al., “Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18,” The Journal of Immunology, vol. 187, no. 11, pp. 5842–5850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Lozovoy, A. Simão, M. S. Hohmann et al., “Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome,” Lupus, vol. 20, no. 13, pp. 1356–1364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Meneshian and G. B. Bulkley, “The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction,” Microcirculation, vol. 9, no. 3, pp. 161–175, 2002. View at Publisher · View at Google Scholar · View at Scopus